Intranigral or intrastriatal injections of GDNF: Effects on monoamine levels and behavior in rats

European Journal of Pharmacology

Volumn 317, Issue 2-3, 1996, Pages 247-256

  Martin, David ^a   Miller, Gerald ^a   Cullen, Tom ^a   Fischer, Norman ^a   Dix, Dan ^a   Russell, Deborah ^a  

^a AMGEN INC   (United States)

Author keywords

Dopamine; GDNF (glial cell line derived neutrophic factor); Monoamine; Parkinson's disease; Striatum; Substantia nigra

Indexed keywords

ADRENALIN; BRAIN MONOAMINE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HOMOVANILLIC ACID; NORADRENALIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DOPAMINERGIC SYSTEM; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; BEHAVIOR, ANIMAL; BIOGENIC MONOAMINES; BODY WEIGHT; BRAIN CHEMISTRY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; INJECTIONS; MALE; MOTOR ACTIVITY; NEOSTRIATUM; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEUROPROTECTIVE AGENTS; RATS; RATS, INBRED F344; RECOMBINANT PROTEINS; SUBSTANTIA NIGRA;

EID: 0030593912     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(96)00756-X     Document Type: Article

References (31)

1. Altar, C.A., C.B. Boylan, C. Jackson, S. Hershenson, J. Miller, S.J. Wiegand, L.M. Lindsay and C. Hyman, 1992, Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo, Proc. Natl. Acad. Sci. USA 89, 11347.
2. Blundell, J.E., 1984, Serotonin and appetite, Neuropharmacology 23, 1537.
3. Buj-Bello, A., V.L. Buchman, A. Horton, A. Rosenthal and A. Davies, 1995, GDNF is an age-specific survival factor for sensory and autonomic neurons, Neuron 15, 821.
4. Cheramy, A., V. Leviel and J. Glowinski, 1981, Dendritic release of dopamine in the substantia nigra, Nature 289, 537.
5. Double, K.L. and A.D. Crocker, 1995, Dopamine receptors in substantia nigra are involved in the regulation of muscle tone, Proc. Natl. Acad. Sci. USA 92, 1669.
6. Espat, N.J., T. Auffenberg, J.J. Rosenberg, M. Rogy, D. Martin, C.H. Fang, P.O. Hasselgren, E.M. Copland III and L.L. Moldawer, 1996, Ciliary neurotrophic factor is a novel mediator of skeletal muscle proteolysis and shares with interleukin-6 the capacity to induce a hepatic acute phase protein response, Am. J. Physiol. 271, R185.
7. Gash, D.M., Z. Zhang, A. Ovadia, W. Cass, D. Russell, D. Martin, F. Collins, B. Hoffer and G. Gerhardt, 1995, Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys, J. Comp. Neurol. 363, 345.
8. Gash, D.M., Z. Zhang, A. Ovadia, W. Cass, A. Yl, L. Simmerman, D. Russell, D. Martin, P.A. Lapchak, F. Collins, B.J. Hoffer and G.A. Gerhardt, 1996, Functional recovery in parkinsonian monkeys treated with GDNF,9 Nature 380, 252.
9. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 1990, 8th edn., eds. A.F. Gilman, T.W. Rall, A.S. Nies and P. Taylor (Pergamon Press, New York, NY) p. 463.
10. Gurney, M.E., H. Yamamoto and Y. Kwon, 1992, Induction of motor neuron sprouting in vivo by ciliary neurotrophic factor and fiboblast growth factor, J. Neurosci. 6, 2155.
11. Henderson, C.E., H.S. Phillips, R.A. Pollack, A.M. Davies, C. Lemeulle, M. Armani, L.C. Simpson, B. Moffet, R.A. Vandlen, V. Koliatsos and A. Rosenthal, 1994, GDNF: a potent survival factor of motoneurons present in peripheral nerve and muscle, Science 266, 1062.
12. Hoffer, B.J., A. Hoffman, K. Bowenkamp, P. Huettl, J. Hudson, D. Martin, L.-F.H. Lin and G.A. Gerhardt, 1994, Glial cell line derived neurotrophic factor reversed toxin-induced injury to mid brain dopaminergic neurons in vivo, Neurosci. Lett. 182, 107.
13. Hudson, J., A.-C. Granholm, G.A. Gerhardt, M.A. Henry, A. Hoffman, P. Biddle, N.S. Leela, L. Mackerlova, J.D. Lile, F. Collins and B.J. Hoffer, 1995 Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo, Brain Res. Bull. 36, 425.
14. Kearns, C.M. and D.M. Gash, 1995, GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo, Brain Res. 672, 101.
15. Lin, L.-F., D. Doherty, J. Lile, S. Bektesh and F. Collins, 1993, GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons, Science 260, 1130.
16. Martin, D., G. Miller, M. Rosendahl and D.A. Russell, 1995, Potent inhibitory effects of glial derived neurotrophic factor against kainic acid mediated seizures in the rat, Brain Res. 683, 172.
17. Martin, D., G. Miller, N. Fischer, D. Dix, T. Cullen and D. Russell, 1996, Glial cell line-derived neurotrophic factor: the lateral cerebral venticle is an effective site of administration for stimulation of the substantia nigra dopamine system in rats, Eur. J. Neurosci. 8, 1249.
18. Martin-Iverson, M.T., K.G. Todd and C.A. Altar, 1994, Brain-derived neurotrophic factor and neurotrophin-3 activate striatal dopamine and serotonin metabolism and related behaviors: interactions with amphetamine, J. Neurosci. 14, 1262.
19. Miller, G., D. Martin and T. Cullen, 1994, Central administration of rhGDNF causes augmentation of dopaminergic activity in vivo, Soc. Neurosci. Abstr. 20, 535.7.
20. Miller, G., D. Martin and F. Collins, 1995, Intracerebroventricular rhGDNF prevents 6-hydroxydopamine mediated nigral cell loss in vivo, Soc. Neurosci. Abstr. 21, 225.11.
21. Opacka-Juffry, J., S. Ashworth, S.P. Hume, D. Martin, D.J. Brooks and S.B. Blunt, 1995, GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET, NeuroReport 7, 348.
22. Oppenheim, R.W., L.J. Houenou, J.E. Johnson, L.-F. Lin, L. Li, A.C. Lo, A.L. Newsome, D.M. Prevette and S. Wang, 1995, Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF, Nature 373, 344.
23. Robertson, G.S. and H.A. Robertson, 1989, Evidence that L-dopa-induced rotational behavior is dependent on both striatal and nigral mechanisms, J. Neurosci. 9, 3326.
24. Rothwell, N.J. and S.J. Hopkins, 1995, Cytokines and nervous system. II: Actions and mechanisms of action, Trends Neurosci. 18, 130.
25. Schaar, D.G., B.A. Siebar, C.F. Dreyfus and I.B. Black, 1993, Regional and cell-specific expression of GDNF in rat brain, Exp. Neurol. 124, 368.
26. Schults, C.W., C. Shin, C. Ernesto and D. Martin, 1995, Effects of intrastriatal injections of glial cell line-derived neurotrophic factor (GDNF) in rats, Soc. Neurosci. Abstr. 21, 225.16.
27. Tomac, A., E. Lindqvist, L.-F. Lin, S.O. Ogren, D. Young, B.J. Hoffer and L. Olson, 1995a, Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo, Nature 373, 335.
28. Tomac, A., J. Widenfalk, L.-F.H. Lin, T. Kohno, T. Ebendal, B.J. Hoffer and L. Olson, 1995b, Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult, Proc. Natl. Acad. Sci. USA 92, 8274.
29. Williams, L.R., 1991, Hyperphagia is induced by intracerebroventricular administration of nerve growth factor, Exp. Neurol. 113, 31.
30. Yan, Q., C. Matheson and O.T. Lopez, 1995, In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons, Nature 373, 341.
31. Zigmond, M.J., T.W. Berger, A.A. Grace and E.M. Stricker, 1989, Compensatory responses to nigrostriatal bundle injury. Studies with 6-hydroxydopamine in an animal model of parkinsonism, Mol. Chem. Neuropathol. 10, 185.